NCT02201901 Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection and Child-Pugh Class B Cirrhosis Status COMPLETED Phase PHASE3
NCT02199613 Elvitegravir/Cobicistat/Tenofovir DF/Emtricitabine With Darunavir Treatment Simplification Strategy Status COMPLETED Phase PHASE4
NCT02196064 Hepatic Safety of Eviplera® in HIV/Hepatitis C (HCV)-Coinfected Patients Without HCV Treatment in the "The HEPAVIR HEPATIC SAFETY Cohort." Status COMPLETED Phase N/A
NCT02185794 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Voxilaprevir in Adults With Chronic Hepatitis C Virus Infection Status COMPLETED Phase PHASE1
NCT02180438 An Open Label Trial of Stribild for Antiretroviral (ARV)-naïve HIV-2 Infected Adults in Dakar, Senegal Status COMPLETED Phase PHASE4
NCT02179710 Cystic Fibrosis Treatment Adherence Cayston Proof-of-Concept Pilot Study Status COMPLETED Phase N/A
NCT02177786 Efficacy, Safety, and Tolerability of Selonsertib (GS-4997) in Participants With Diabetic Kidney Disease Status COMPLETED Phase PHASE2
NCT02176876 Safety, Tolerability, and Pharmacokinetics of GS-5745 in Subjects With Rheumatoid Arthritis Status COMPLETED Phase PHASE1
NCT02175758 Safety and Efficacy of Sofosbuvir + Ribavirin in Adolescents and Children With Genotype 2 or 3 Chronic HCV Infection Status COMPLETED Phase PHASE2
NCT02174276 Safety and Efficacy of GS-4774 in Combination With Tenofovir Disoproxil Fumarate (TDF) for the Treatment of Participants With Chronic Hepatitis B (CHB) and Who Are Currently Not on Treatment Status COMPLETED Phase PHASE2
NCT02167100 Patient Retention in HIV Medical Care in a Primary Care Practice in Australia Status COMPLETED Phase N/A
NCT02166047 Study To Evaluate Safety and Efficacy of Vesatolimod for the Treatment of Chronic Hepatitis B Virus in Virally-Suppressed Participants Status COMPLETED Phase PHASE2
NCT02161679 Phase II Study of IMMU-132 Alone or in Combination With Carboplatin in Patients With Triple-Negative Breast Cancer Status WITHDRAWN Phase PHASE2
NCT02156336 Ranolazine for Diabetic Peripheral Neuropathic Pain (DPNP) Status TERMINATED Phase PHASE4
NCT02149888 PRe-Exposure Prophylaxis Acceptability & Readiness Assessments for Toronto gaY, Bisexual and Other Men Who Have Sex With Men-5 Status COMPLETED Phase PHASE4
NCT02147834 Effectiveness of Ranolazine on Reducing Chest Pain in Patients With Blockage But no Stents Status TERMINATED Phase PHASE2
NCT02147067 Microvascular Assessment of Ranolazine in Non-Obstructive Atherosclerosis (MARINA) Status COMPLETED Phase PHASE2
NCT02136511 Expanded Access for Idelalisib in Combination With Rituximab in Chronic Lymphocytic Leukemia Status APPROVED_FOR_MARKETING Phase N/A
NCT02135614 Efficacy, Pharmacokinetics, and Safety of Presatovir in Hospitalized Adults With Respiratory Syncytial Virus (RSV) Infection Status COMPLETED Phase PHASE2